AAAAAA

   
Results: 1-2 |
Results: 2
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANC CYTOP, 91(1), 2001, pp. 144-154
A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease
Authors: Berenson, JR Vescio, R Henick, K Nishikubo, C Rettig, M Swift, RA Conde, F Von Teichert, JM
Citation: Jr. Berenson et al., A phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease, CANCER, 91(1), 2001, pp. 144-154
Risultati: 1-2 |